Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab

Mario Cazzola*, Maria Gabriella Matera, Francesca Levi-Schaffer, Paola Rogliani

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science